3M report “3M Critical and Chronic Care Solutions today announces the launch of its new 3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Port Dressing, designed for patients with implanted port devices under their skin and connected to a catheter for the purpose of central venous infusions. This announcement coincides with the Oncology Nursing Society (ONS) 40th Annual Congress show in Orlando, Fla.
3M launches new Tegaderm CHG implantable port dressing http://ctt.ec/a4lWs+ @ivteam #ivteam
The new offering combines, for the first time, a transparent, port-site dressing with a separate, compatible antimicrobial CHG gel pad device that’s also clear and designed specifically for ports. This allows for continuous, unobstructed observation of the I.V. insertion site, even in the presence of saline, blood and exudates”.More News
Thank you to our partners for supporting IVTEAM